Brown Brothers Harriman & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,321	Closed	-$24K	–	1554
2022 Q3	$24K	Hold	1,321	–	–	﹤0.01%	934
2022 Q2	$13K	Hold	1,321	–	–	﹤0.01%	974
2022 Q1	$22K	Buy	+1,321	New	+$19.5K	﹤0.01%	915
2017 Q1	–	Sell	-99	Closed	–	–	899
2016 Q4	$0	Hold	99	–	–	﹤0.01%	880
2016 Q3	$5K	Hold	99	–	–	﹤0.01%	694
2016 Q2	$5K	Buy	+99	New	+$4.92K	﹤0.01%	720

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Brothers Harriman & Co's ISEE Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 1,321 shares — an estimated $24K sold.

Brown Brothers Harriman & Co first reported a position in ISEE in Q2 2016 and held it in 6 quarters. The position peaked at $24K in Q3 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

Brown Brothers Harriman & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Brown Brothers Harriman & Co sold 1,321 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $24K.
Brown Brothers Harriman & Co first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
Brown Brothers Harriman & Co's IVERIC bio, Inc. Common Stock position peaked at $24K in Q3 2022.
225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.